leadf
logo-loader
CSE:HUGE NASDAQ:HUGE

FSD Pharma

Receive alerts
Market:
CSE
Market Cap:
$54.47 m
Price
3.67 CAD
Change
3.09%
52 weeks high
19.10
52 weeks low
3.35

In brief

FSD Pharma Inc. is a publicly-traded holding company, since May 2018.

FSD Pharma BioSciences, Inc., a wholly-owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound, ultramicronized-palmitoylethanolamide (“FSD201”), by down-regulating the cytokines to effectuate an anti-inflammatory response.

Snapshot

The indoor hydroponic facility will be optimized for large-scale, medical-grade cannabis production and once complete, is expected to have over 3.9 million sq/ft available for production